Yenidoğan Hirschsprung Hastalığında Preoperatif Dönem Semptomatik Olma Süresinin Tedavi Sonuçları Üzerine Etkisi

Year 2025, Volume: 18 Issue: 1 , 102 - 108 , 29.04.2025

İsa Kıllı , Ayşen Orman , Hakan Taşkınlar , Caner İsbir , Emre Çocuk

https://doi.org/10.26559/mersinsbd.1579271

https://izlik.org/JA92UW29UT

Abstract

Amaç: Hirschsprung hastalığının yenidoğanlardaki preoperatif dönemde semptomatik olma süresinin tedavi sonuçları üzerine olan etkisinin araştırılmasıdır. Yöntem: Çalışmaya Ocak 2014-Ocak 2024 tarihleri arasında Mersin Üniversitesi Tıp Fakültesi Hastanesi Yenidoğan Yoğun Bakım ünitesinde Hirschsprung hastalığı nedeni ile tedavi edilen ve kolostomi açılan 15 hasta dahil edildi. Hastaların preoperatif klinik durumları, kolostomi açılma yaşları (= preoperatif dönem izlem süresi), kısa ve uzun segment Hirschsprung hastalığı olma durumları, postoperatif komplikasyonları kaydedildi. Hastaların kolostomi açılma yaşları, preoperatif klinik özelliklerine ve postoperatif komplikasyon durumlarına göre analiz edildi. Bulgular: Ortalama kolostomi açılma yaşı preoperatif dönemde intestinal pasaj sorunu (n=6), ileus (n=8) veya intestinal perforasyon (n=1) deneyimleyen hastalarda istatistiksel farklılık göstermedi (p=0.597). Postoperatif komplikasyon gelişen hastaların (n=6) ortalama kolostomi açılma yaşı, postoperatif komplikasyon gelişmeyen hastalara (n=9) göre daha büyük saptandı (88.8±8.3 güne karşılık 28.1±9.1 gün, p<0.001). Sonuç: Yenidoğan Hirschsprung hastalığında nonspesifik bulgular ayırıcı tanı konusunda güçlükler oluşturmakta ve bu durum tanı ve tedavi süreçlerini uzatıp beraberinde morbiditeyi arttırmaktadır. Bu nedenle yenidoğanlarda intestinal pasaj sorunlarının yönetiminde süreç zamanlaması ile postoperatif komplikasyonlar arasındaki olası ilişkinin dikkate alınmalıdır.

Keywords

Hirschsprung hastalığı , yenidoğan , komplikasyon

Ethical Statement

ÇALIŞMANIN KLİNİK ARAŞTIRMALAR ETİK KURULU ALINMIŞTIR.

Supporting Institution

YOKTUR

The Impact of the Duration of Preoperative Symptomatic Period on Treatment Outcomes in Neonatal Hirschsprung's Disease

https://izlik.org/JA92UW29UT

Abstract

Aim: To investigate the effect of the duration of symptomatic period in the preoperative phase of Hirschsprung's disease on treatment outcomes in newborns. Methods: A retrospective study was conducted on 15 neonates diagnosed with Hirschsprung's disease and who underwent colostomy at Mersin University Faculty of Medicine Hospital between January 2014 and January 2024. Patient data including preoperative clinical status, age at colostomy (serving as a proxy for preoperative symptom duration), presence of short-segment or long-segment disease, and postoperative complications were collected. The primary objective was to investigate the correlation between age at colostomy and preoperative clinical features, as well as postoperative outcomes. Results: There was no statistically significant difference in the mean age at colostomy among patients presenting with preoperative intestinal passage problems (n=6), ileus (n=8), or perforation (n=1) (p=0.597). However, patients who developed postoperative complications (n=6) had a significantly higher mean age at colostomy compared to those without complications (n=9) (88.8±8.3 days vs. 28.1±9.1 days, p<0.001). Conclusion: The nonspecific nature of presenting symptoms in neonates with Hirschsprung's disease poses challenges in differential diagnosis, often leading to delays in diagnosis and treatment, thereby increasing morbidity. Consequently, the possible relationship between the onset of intestinal passage problems and the development of postoperative complications should be taken into consideration in the management of intestinal passage problems in newborns.

Keywords

Hirschsprung disease , newborn , complication

References

• Parisi MA, Kapur RP. Genetics of Hirschsprung disease. Current Opinion in Pediatrics. 2000; 12(6): 610-617.
• Haricharan RN, Georgeson KE. Hirschsprung disease. Semin Pediatr Surg. 2008;17(4):266-275. doi:10.1053/j.sempedsurg.2008.07.005
• Singh SJ, Croaker GD, Manglick P, et al. Hirschsprung's disease: the Australian Paediatric Surveillance Unit's experience. Pediatr Surg Int. 2003;19(4):247-250. doi:10.1007/s00383-002-0842-z
• Teitelbaum DH, Cilley RE, Sherman NJ, et al. A decade of experience with the primary pull-through for hirschsprung disease in the newborn period: a multicenter analysis of outcomes. Ann Surg. 2000;232(3):372-380. doi:10.1097/00000658-200009000-00009
• Bill HA, Chapman ND. The enterocolitis of Hirschsprung's disease: its natural history and treatment. The American Journal of Surgery. 1962; 103(1): 70-74.
• Teitelbaum DH, Qualman SJ, Caniano DA. Hirschsprung's disease. Identification of risk factors for enterocolitis. Ann Surg. 1988;207(3):240-244. doi:10.1097/00000658-198803000-00003
• Murthi GV, Raine PA. Preoperative enterocolitis is associated with poorer long-term bowel function after Soave-Boley endorectal pull-through for Hirschsprung's disease. J Pediatr Surg. 2003;38(1):69-72. doi:10.1053/jpsu.2003.50013
• Menezes M, Puri P. Long-term outcome of patients with enterocolitis complicating Hirschsprung's disease. Pediatr Surg Int. 2006;22(4):316-318. doi:10.1007/s00383-006-1639-2
• Holschneider AM, Puri P. Hirschsprung's disease and allied disorders. 3. Baskı. Berlin: Springer; 2000
• Coran AG, Teitelbaum DH. Recent advances in the management of Hirschsprung's disease. Am J Surg. 2000;180(5):382-387. doi:10.1016/s0002-9610(00)00487-6
• Hackam DJ, Reblock KK, Redlinger RE, Barksdale EM Jr. Diagnosis and outcome of Hirschsprung's disease: does age really matter?. Pediatr Surg Int. 2004;20(5):319-322. doi:10.1007/s00383-004-1188-5
• Nakagawa Y, Uchida H, Hinoki A, et al. Preoperative management comprising tube irrigation using a trans-anal indwelling tube for infants with hirschsprung disease can allow single-stage radical surgery. BMC Surg. 2023;23(1):333. Published 2023 Nov 1. doi:10.1186/s12893-023-02232-y
• Huddart SN. Hirschsprung's disease: present UK practice. Ann R Coll Surg Engl. 1998;80(1):46-48.
• So HB, Schwartz DL, Becker JM, Daum F, Schneider KM. Endorectal "pull-through" without preliminary colostomy in neonates with Hirschsprung's disease. J Pediatr Surg. 1980;15(4):470-471. doi:10.1016/s0022-3468(80)80755-x
• Georgeson KE, Fuenfer MM, Hardin WD. Primary laparoscopic pull-through for Hirschsprung's disease in infants and children. J Pediatr Surg. 1995;30(7):1017-1022. doi:10.1016/0022-3468(95)90333-x
• Venugopal S, Mancer K, Shandling B. The validity of rectal biopsy in relation to morphology and distribution of ganglion cells. J Pediatr Surg. 1981;16(4):433-437. doi:10.1016/s0022-3468(81)80001-2
• Langer JC. Surgical approach to Hirschsprung disease. Semin Pediatr Surg. 2022;31(2):151156. doi:10.1016/j.sempedsurg.2022.151156
• Ullrich S, Austin K, Avansino JR, et al. Does Delayed Diagnosis of Hirschsprung Disease Impact Post-operative and Functional Outcomes? A Multi-Center Review From the Pediatric Colorectal and Pelvic Learning Consortium. J Pediatr Surg. 2024;59(7):1250-1255. doi:10.1016/j.jpedsurg.2024.03.034
• Westfal ML, Okiemy O, Chung PHY, et al. Optimal timing for Soave primary pull-through in short-segment Hirschsprung disease: A meta-analysis. J Pediatr Surg. 2022;57(4):719-725. doi:10.1016/j.jpedsurg.2021.07.007
• Singh SJ, Croaker GD, Manglick P, et al. Hirschsprung's disease: the Australian Paediatric Surveillance Unit's experience. Pediatr Surg Int. 2003;19(4):247-250. doi:10.1007/s00383-002-0842-z